Case Study

Science 37 Delivers Diverse Patient Enrollment in Respiratory Clinical Trial

In a study for a respiratory syncytial virus (RSV) vaccine, Science 37 was contracted to…

Case Study

Science 37 Accelerates Enrollment for Dermatology Clinical Trial

A biopharma company was conducting a Phase 2 randomized controlled trial in the United States…

Case Study

Science 37 Launches Infectious Disease Prevention Study in Just 12 Weeks

A biotech sponsor contracted Science 37 to help enroll patients in a global Phase 2/3…

Case Study

Science 37 Accelerates Oncology Clinical Trial Timeline by 3 Years

A biopharma company was investigating how its diagnostic screening technology—a one-time blood sample—performed against the…

Scientific Poster

Preliminary Results from an Interventional Decentralized Clinical Trial

A top pharma company partnered with Science 37 to conduct the first-ever interventional decentralized clinical…

Case Study

The Direct-to-Patient Site in Action: A Case Study Collection

The Science 37 Direct-to-Patient Site is a virtual site that expands patient access to clinical trials…

Case Study

The Science 37 Direct-to-Patient Site in Action: A Fully Decentralized Trial for a Rare Vascular Disorder

A biopharma company was planning a Phase III, randomized, double-blind, placebo-controlled clinical trial for a…

Case Study

The Science 37 Direct-to-Patient Site in Action: How Science 37 Accelerated Enrollment for a Dermatology Trial

A biopharma company was conducting a Phase II randomized controlled clinical trial in the United…

Case Study

Decentralized in Action: How Science 37 Accelerated Enrollment for a Diagnostic Oncology Trial

A biopharma company was investigating how its diagnostic screening technology—a one-time blood sample—performed against the…

Case Study

The Science 37 Direct-to-Patient Site in Action: Accelerating Enrollment for an Infectious Disease Trial

A biopharma company was conducting a phase II randomized controlled trial for an infectious disease.…

Case Study

Science 37 Uses the Direct-to-Patient Site to Support Clinical Trial in Rare Neurodegenerative Disease

An industry leading pharmaceutical company implemented the Science 37’s Direct-to-Patient Site to reduce patient patient…

Case Study

Science 37 Utilizes Flexibility of the Direct-to-Patient Site Model in Study of Rare Disease

A biotech company approached Science 37 to develop a virtualized process to evaluate patients who may…